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Abstract: Since evidence became available that free radicals were involved in mechanisms 
for the development of major diseases, including cardiovascular disease and cancer, there 
has been considerable research into the properties of natural dietary antioxidants. However, 
it has become clear that dietary antioxidants can only have beneficial effects in vivo by 
radical scavenging or effects on redox potential if they are present in tissues or bodily 
fluids at sufficient concentrations. For many dietary components, absorption is limited or 
metabolism into derivatives reduces the antioxidant capacity. For many dietary phytochemicals, 
direct antioxidant effects may be less important for health than other effects including 
effects on cell signalling or gene expression in vivo. 
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1. Introduction 
It has been recognised that reactive oxygen species (ROS) generated by mitochondria, phagocytes, 
peroxisomes, and cytochrome P450 enzymes may cause damage to cellular DNA, proteins and lipids. 
The antioxidant hypothesis was a development from the lipid hypothesis, which related risk of 
developing cardiovascular disease (CVD) to high saturated fat intake and elevated plasma cholesterol 
levels [1,2]. Intervention trials failed to correlate reduction of plasma cholesterol levels by diet with 
reduction in cardiovascular disease, so the antioxidant hypothesis focussed attention on the potential 
for dietary antioxidants to reduce the impact of ROS. It provided an explanation for the reduction in 
risk of cardiovascular disease arising from increased consumption of fruit and vegetables which has 
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been confirmed by meta analysis [3]. The antioxidant hypothesis proposed that low-density lipoprotein 
(LDL) cholesterol penetrates the endothelial wall into the sub-endothelial space, where it is susceptible 
to oxidation by free radicals, smooth muscle cells or macrophages. Oxidised LDL cholesterol is not 
recognised by the LDL receptors, so it is not cleared from the circulation but it is preferentially taken 
up by macrophages which become engorged and develop into foam cells. Toxic products are deposited 
into cells, and fatty streaks form from the foam cells, which develop into atherosclerotic plaques, and 
consequently play a role in the aetiology of CVD. Vitamin E is the main antioxidant in LDL, but 
carotenoids may also contribute to the stability of the LDL particle. Other antioxidants may play a role 
by reducing oxidative stress in plasma, and improving retention of antioxidants in LDL or reducing 
oxidative damage of Apo B-100, which is the protein in the LDL particle. 
2. Plasma Antioxidant Capacity 
There have been many studies of the antioxidant activity of food components. Dietary components 
with strong antioxidant activity under selected conditions include vitamin C, vitamin E, carotenoids, 
and flavonoids. The most common antioxidant mechanisms in vitro involve hydrogen-atom transfer, 
electron donation or metal chelation [4], although carotenoids are also effective singlet oxygen 
quenchers, which can be important in tissues, e.g., skin, where activation of oxygen may occur [5]. 
Increases in plasma antioxidant capacity or related measures of antioxidant effects of dietary 
phytochemicals have often been observed [6–8], but effects of foods containing dietary antioxidants on 
health outcomes cannot be demonstrated to be due to their antioxidant properties [9,10]. Endogenous 
compounds (glutathione, ubiquinol, uric acid, bilirubin) and enzymes (superoxide dismutase, catalase, 
glutathione peroxidase) also make major contributions to the detoxification of ROS. Uric acid, which 
is a product of purine metabolism, contributes 60–70% of plasma antioxidant capacity [11]. It has been 
shown to act as an intracellular free radical scavenger and it is active in reducing oxidative stress by 
reacting with ROS including nitric oxide, peroxyl radicals and hydroxyl radicals. An increase in 
plasma antioxidant capacity was demonstrated in volunteers who consumed apple juice but this was 
shown to be due to the increase in serum uric acid concentrations and was not due to the presence of 
antioxidant polyphenols in the juice [12]. However, elevated serum uric acid concentrations are often 
observed in subjects with chronic heart failure and metabolic syndrome, and serum uric acid has been 
proposed as an independent predictor for all major forms of cardiovascular death [13]. 
Uric acid occurs in plasma at concentrations of 200–500 µmol/L, which is much higher than   
the concentration of dietary antioxidants. Vitamin C is the dietary antioxidant that occurs at highest 
concentrations in plasma. However, plasma becomes saturated with vitamin C at about 70 µmol/L, 
which can be achieved by dietary intake of about 200 mg/day. Vitamin C is well absorbed by individuals 
who have a low plasma concentration, but once plasma becomes saturated, excess vitamin C is excreted. 
Epidemiological studies have provided evidence that plasma vitamin C concentration is inversely related 
to risk of CVD and/or all cause mortality, but clinical trials have not provided clear evidence to 
support the beneficial effects of vitamin C. Although supplementation with vitamin C may not benefit 
the general population, a large subpopulation has low plasma concentrations of vitamin C [14] and 
supplementation with vitamin C may be beneficial for individuals with low plasma vitamin C 
concentrations [15]. Int. J. Mol. Sci. 2012, 13 175 
 
2.1. Carotenoids 
Carotenoids are partially absorbed from food, but their bioavailability varies widely, being 
dependent on the food matrix, and the carotenoid structure [16]. Absorption of carotenoids involves 
release from plant cells, and the formation of micelles which requires dietary fat and bile acids [17]. 
The carotenes are absorbed by passive diffusion through the intestinal brush border membrane into 
enterocytes, but for xanthophylls, e.g., lutein, absorption is a facilitated process that requires a class  
b-type 1 scavenger receptor (SR-B1) [18]. Carotenoids are incorporated into chylomicrons and 
released into the lymphatic system. They are then incorporated into lipoproteins in the liver and 
released into the blood stream. Absorption of carotenoids is a relatively slow process with peak plasma 
concentrations reached at up to 24 h after consumption of the food [19]. 
The effects of dietary supplementation with β-carotene were investigated in two intervention trials 
namely the CARET (β-carotene and retinol efficacy trial) and the ATBC (α-tocopherol and β-carotene 
for cancer prevention) study [20]. Both the CARET and the ATBC study were set up to examine the 
effects of vitamin supplementation on individuals at high risk of developing lung cancer due to smoking 
or exposure to asbestos. However, the trials provided evidence of increased morbidity and mortality in the 
vitamin-supplemented group [21]. 
Lutein and zeaxanthin are the only carotenoids that occur in the eye, where they are particularly 
concentrated in the centre of the retina, the macula lutea. They have been identified as being important 
for resistance to macular degeneration of the retina [22]. Eyes are constantly exposed to ROS, which 
may be formed due to the influence of UV radiation, which can pass through the cornea and enter the 
lens. The effect of the carotenoids in absorbing light in the blue and UV region without generating 
ROS, and in acting as antioxidants by combining with ROS to reduce their activity, makes an 
important contribution to maintaining the integrity of the retina. 
2.2. Flavonoids 
There has been much interest in dietary flavonoids in recent years. Flavonoids have a common 
structure consisting of 2 aromatic rings (A and B) that are linked together by 3 carbon atoms, which 
form an oxygenated heterocyclic ring (ring C) for most flavonoids, although the linking carbons may 
be in an open chain form for anthocyanins under some conditions. Flavonoids are divided into   
6 subclasses: flavonols, flavones, flavanones, flavanols, anthocyanins, and isoflavones. Individual 
differences within each group arise from the variation in the number and arrangement of the   
hydroxyl groups and their alkylation and/or glycosylation. Flavonoids are highly active as antioxidants 
in vitro by hydrogen atom transfer, electron donation or metal chelation [4]. Many flavonoids are 
poorly absorbed from food [23,24]. In the small intestine, flavonoid glucosides may be partly 
converted to the aglycone by hydrolysis by lactase phlorodzin hydrolase in the brush-border 
 and they may then enter cells by passive diffusion [23]. Alternatively, flavonoid glucosides may be 
transported into cells, and then hydrolysed by cytosolic β-glucosidase [23]. However, a considerable 
fraction of ingested flavonoids passes into the large intestine, where colonic microbiota cleave 
conjugates, and form phenolic acids and hydroxycinnamates. Isoflavones including daidzein-7-O-
glucosides from soya are reported to reach plasma concentrations up to 3 µM, but other classes reach  Int. J. Mol. Sci. 2012, 13 176 
 
plasma concentrations < 1 µM after supplementation (Table 1). The nature of the sugar can affect the 
uptake of dietary flavonoids. Thus quercetin-4′-O-glucoside and quercetin-3,4′-O-diglucoside from 
onions reached maximum plasma concentrations in <1 h and 4.7% of intake was recovered in the urine 
[25]. In contrast when quercetin-3-O-rutinoside was consumed in tomato juice, uptake was much 
slower with time to maximum plasma concentrations ca. 5 h, and only 0.02–2.8% of intake was 
recovered in the urine [26]. These studies confirmed that the absorption of rutinosides in the small 
intestine was minimal with slower absorption being consistent with absorption from the large intestine. 
Tea is one of the main sources of flavonoids in the diet. After consumption of green tea, peak plasma 
concentrations of epigallocatechin gallate, epigallocatechin and epicatechin were reported as 0.04–1 µM, 
0.3–5 µM and 0.1–2.5 µM, respectively, in humans [27], but the theaflavins and thearubigins in black 
tea were less well absorbed with peak plasma concentrations of 2 nM reported for the theaflavins. 
Table 1. Bioavailability of selected flavonoids. 
Flavonoid Occurrence 



















Orange juice 4.4 h  900 nmol/L  17.3%  [29] 
Flavonol rutinosides  Tomato juice 5h  <12 nmol/L  0.02–2.8%  [26] 
Flavonol glucosides  onions  <1 h  <665 nmol/L  4.7%  [25] 
Isoflavones— 
daidzein-7-O-glucosides 





1.3 h  32 nmol/L  <0.25%  [31] 
The physiological effects of phenolic acids are poorly understood, but effects on gene expression of 
antioxidant enzymes have been demonstrated. Thus protocatechuic acid, one of the main metabolites 
of anthocyanins, has been shown to induce the expression of antioxidant, detoxifying enzymes through 
c-Jun N-terminal kinase (JNK)-mediated nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation [32]. 
Flavonoids have also been shown to exert effects on cell signalling and gene expression. An extract 
from cocoa rich in flavonoids has been shown to suppress tumor necrosis factor (TNF-α)-induced 
vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and 
mitogen-activated protein kinase kinase-1 (MEK1) activities [33]. 
In addition, the antioxidant activity of many flavonoids is reduced by metabolism. Flavonoids are 
derivatised extensively by glucuronidation, methylation, and sulfation in the intestinal mucosa and the 
liver [34,35]. The antioxidant activity of derivatives is commonly less than that of the parent flavonoid, 
as shown for methylation or sulfation of quercetin [36]. Int. J. Mol. Sci. 2012, 13 177 
 
3. Conclusion 
Thus, it is clear that many phytochemicals occur at low concentrations in plasma and tissues. They 
have many physiological effects, and supplementation with dietary antioxidants at doses that give rise 
to elevated concentrations in plasma and tissues may cause adverse effects. For the flavonoids, 
antioxidant activity is reduced by metabolism. Effects of dietary antioxidants on cell signalling and 
gene expression, where effects can be demonstrated at low concentrations, may be more important for 
health benefits than direct antioxidant activity. 
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